Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.144
-0.156 (-12.02%)
Apr 28, 2026, 4:00 PM EST
Nuo Therapeutics Employees
Nuo Therapeutics had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$331,351
Profits / Employee
-$251,222
Market Cap
55.36M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cell Source | 1 |
| Vicapsys Life Sciences | 2 |
| Harvard Apparatus Regenerative Technology | 8 |
| Provectus Biopharmaceuticals | 6 |
| Vaxart | 65 |
| Anebulo Pharmaceuticals | 3 |
Nuo Therapeutics News
- 1 year ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 1 year ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 3 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire